796
Views
38
CrossRef citations to date
0
Altmetric
Research Article

CD22 and Autoimmune Disease

, &
Pages 363-378 | Accepted 25 Jun 2012, Published online: 19 Oct 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Daniel Geh & Caroline Gordon. (2018) Epratuzumab for the treatment of systemic lupus erythematosus. Expert Review of Clinical Immunology 14:4, pages 245-258.
Read now
Matthias Cassia, Federico Alberici, Maurizio Gallieni & David Jayne. (2017) Lupus nephritis and B-cell targeting therapy. Expert Review of Clinical Immunology 13:10, pages 951-962.
Read now

Articles from other publishers (36)

N.J. Carruthers, C. Guo, R. Gill, P.M. Stemmer & A.J. Rosenspire. (2023) Mercury intoxication disrupts tonic signaling in B cells, and may promote autoimmunity due to abnormal phosphorylation of STIM-1 and other autoimmunity risk associated phosphoproteins involved in BCR signaling. Toxicology and Applied Pharmacology 474, pages 116607.
Crossref
Shujie Liu, Xin Tao, Bo Deng, Yongming Li & Ziwei Xu. (2023) Genome-Wide Analysis of Long Noncoding RNAs in Porcine Intestine during Weaning Stress. International Journal of Molecular Sciences 24:6, pages 5343.
Crossref
Youxia Liu, Hongfen Li, Huyan Yu, Fanghao Wang, Haiyan Cao, Junya Jia & Tiekun Yan. (2023) Deciphering prognostic value of CD22 and its contribution to suppression of proinflammatory cytokines production in patients with IgA nephropathy. Immunology Letters 255, pages 40-46.
Crossref
Zhibiao Li, Zechao Lu, Chuxian Hu, Yixin Zhang, Yushu Chen, Jiahao Zhang, Feng Guo, Jinjin Wang, Zhicheng Tang, Fucai Tang & Zhaohui He. (2023) A Machine Learning Analysis of Prognostic Genes Associated With Allograft Tolerance After Renal Transplantation. Cell Transplantation 32.
Crossref
Ping Ren, Lei Peng, Luojia Yang, Kazushi Suzuki, Zhenhao Fang, Paul A. Renauer, Qianqian Lin, Meizhu Bai, Tongqing Li, Paul Clark, Daryl Klein & Sidi Chen. (2023) RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seq. Cell Chemical Biology 30:1, pages 85-96.e6.
Crossref
Joni V. Lindbohm, Nina Mars, Pyry N. Sipilä, Archana Singh-Manoux, Heiko Runz, Gill Livingston, Sudha Seshadri, Ramnik Xavier, Aroon D. Hingorani, Samuli Ripatti & Mika Kivimäki. (2022) Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases. Nature Aging 2:10, pages 956-972.
Crossref
Behnaz Rashidieh, Alireza Madjid Ansari, Mahdi Behdani, Behrad Darvishi & Mahdi Habibi-Anbouhi. (2022) Extremely low frequency magnetic field enhances expression of a specific recombinant protein in bacterial host. Analytical Biochemistry 652, pages 114745.
Crossref
Gina P. Sykes, Joseph Kamtchum-Tatuene, Sarina FalcioneSarah ZehnderDanielle MunstermanBoryana StamovaBradley P. AnderFrank R. SharpGlen Jickling. (2021) Aging Immune System in Acute Ischemic Stroke. Stroke 52:4, pages 1355-1361.
Crossref
Shankargouda Patil, Vidya Gs, Gargi S. Sarode, Sachin C. Sarode, Turki Abdu Khurayzi, Saiid Elshafey Mohamed Beshir, Amol R. Gadbail & Shailesh Gondivkar. (2021) Exploring the role of immunotherapeutic drugs in autoimmune diseases: A comprehensive review. Journal of Oral Biology and Craniofacial Research 11:2, pages 291-296.
Crossref
Cristina Di Carluccio, Rosa Ester Forgione, Marco Montefiori, Monica Civera, Sara Sattin, Giovanni Smaldone, K. Fukase, Y. Manabe, Paul R. Crocker, Antonio Molinaro, Roberta Marchetti & Alba Silipo. (2021) Behavior of glycolylated sialoglycans in the binding pockets of murine and human CD22. iScience 24:1, pages 101998.
Crossref
Na Xiao, Shanfeng Hao, Yang Zhang & Zonghong Shao. (2020) Roles of immune responses in the pathogenesis of immunorelated pancytopenia. Scandinavian Journal of Immunology 92:2.
Crossref
A. V. Zaychenko, N. A. Gorchakova, O. V. Shumeiko, O. V. Klymenko & O. V. Khodakivska. (2019) Spectrum of Pharmacological Activity of Monoclonal Antibodies. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 4:5, pages 17-32.
Crossref
Jian Li, Ming‑Ming Wei, Qin Song, Xiang‑Hua Guo, Li Shao & Yan Liu. (2019) Anti‑CD22 epratuzumab for systemic lupus erythematosus: A systematic review and meta‑analysis of randomized controlled trials. Experimental and Therapeutic Medicine.
Crossref
Natalia V. Giltiay, Geraldine L. Shu, Anthony Shock & Edward A. Clark. (2017) Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling. Arthritis Research & Therapy 19:1.
Crossref
Laurie S. Davis & Andreas M. Reimold. (2017) Research and therapeutics—traditional and emerging therapies in systemic lupus erythematosus. Rheumatology 56:suppl_1, pages i100-i113.
Crossref
Mette Marcussen, Julie Støve Bødker, Heidi Søgaard Christensen, Preben Johansen, Søren Nielsen, Ilse Christiansen, Olav Jonas Bergmann, Martin Bøgsted, Karen Dybkær, Mogens Vyberg & Hans Erik Johnsen. (2017) Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa. PLOS ONE 12:1, pages e0169286.
Crossref
Qian Zhao, Xia Chen, Jing Li, Ji Jiang, Mengtao Li, Wen Zhong, Zhengdong Li, Shui-on Leung, Fengchun Zhang & Pei Hu. (2016) Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus. Clinical Drug Investigation 36:11, pages 889-902.
Crossref
Simon Lumb, Sarah J. Fleischer, Annika Wiedemann, Capucine Daridon, Alison Maloney, Anthony Shock & Thomas Dörner. (2016) Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor. Journal of Cell Communication and Signaling 10:2, pages 143-151.
Crossref
Sarah J. Fleischer, Capucine Daridon, Vanessa Fleischer, Peter E. Lipsky & Thomas Dörner. (2016) Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells. Arthritis & Rheumatology 68:5, pages 1210-1221.
Crossref
D. J. Wallace, K. Hobbs, M. E. B. Clowse, M. Petri, V. Strand, M. Pike, J. T. Merrill, P. Leszczyński, C. M. Neuwelt, S. Jeka, F. Houssiau, M. Keiserman, J. Ordi-Ros, S. Bongardt, B. Kilgallen, C. Galateanu, K. Kalunian, R. Furie & C. Gordon. (2016) Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study. Arthritis Care & Research 68:4, pages 534-543.
Crossref
Sander W. Tas & Dominique L. P. Baeten. 2016. Suppression and Regulation of Immune Responses. Suppression and Regulation of Immune Responses 143 155 .
Thomas Dörner, Anthony Shock, David M. Goldenberg & Peter E. Lipsky. (2015) The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus. Autoimmunity Reviews 14:12, pages 1079-1086.
Crossref
Takashi Angata, Corwin M. Nycholat & Matthew S. Macauley. (2015) Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches. Trends in Pharmacological Sciences 36:10, pages 645-660.
Crossref
Flavia Orizio, Eufemia Damiati, Edoardo Giacopuzzi, Giuliana Benaglia, Stefano Pianta, Roland Schauer, Reinhard Schwartz-Albiez, Giuseppe Borsani, Roberto Bresciani & Eugenio Monti. (2015) Human sialic acid acetyl esterase: Towards a better understanding of a puzzling enzyme. Glycobiology 25:9, pages 992-1006.
Crossref
Michael D. Rosenblum, Kelly A. Remedios & Abul K. Abbas. (2015) Mechanisms of human autoimmunity. Journal of Clinical Investigation 125:6, pages 2228-2233.
Crossref
Thomas Tschernig, Christina Hartwig, Andreas Jeron, Quoc Thai Dinh, Marcus Gereke & Dunja Bruder. (2015) First Genomic Analysis of Dendritic Cells from Lung and Draining Lymph Nodes in Murine Asthma. International Journal of Genomics 2015, pages 1-7.
Crossref
Vijay Rao & Caroline Gordon. (2014) Evaluation of epratuzumab as a biologic therapy in systemic lupus erythematosus. Immunotherapy 6:11, pages 1165-1175.
Crossref
Monika Podhorecka, Justyna Markowicz, Agnieszka Szymczyk & Johannes Pawlowski. (2014) Target Therapy in Hematological Malignances: New Monoclonal Antibodies. International Scholarly Research Notices 2014, pages 1-16.
Crossref
Penelope Ward & Mark Bodmer. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 851 926 .
Marloes J.M. Olde Nordkamp, Bobby P. Koeleman & Linde Meyaard. (2014) Do inhibitory immune receptors play a role in the etiology of autoimmune disease?. Clinical Immunology 150:1, pages 31-42.
Crossref
Ana M. Avalos, Friederike Meyer-Wentrup & Hidde L. Ploegh. 2014. Cell Biology of the B Cell Receptor. Cell Biology of the B Cell Receptor 1 49 .
Markus Biburger, Anja Lux & Falk Nimmerjahn. 2014. 67 94 .
Ignacio Sanz. 2014. Drugs Targeting B-Cells in Autoimmune Diseases. Drugs Targeting B-Cells in Autoimmune Diseases 37 64 .
Dorith Claes, Malte Holzapfel, Nadine Clausen & Wolfgang Maison. (2013) Synthesis of Adamantane-Based Trimeric Benzoboroxoles. European Journal of Organic Chemistry 2013:28, pages 6361-6371.
Crossref
DJ Wallace & DM Goldenberg. (2013) Epratuzumab for Systemic Lupus Erythematosus. Lupus 22:4, pages 400-405.
Crossref
M. Schaller, J.-D. Studt, J. Voorberg & J. A. Kremer Hovinga. (2018) Acquired thrombotic thrombocytopenic purpura. Hämostaseologie 33:02, pages 121-130.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.